Literature DB >> 12717240

Immunosuppression with FTY720 and cyclosporine A inhibits rejection of adult porcine islet xenografts in rats.

A Maeda1, M Goto, J Zhang, W Bennet, C G Groth, O Korsgren, L Wennberg.   

Abstract

BACKGROUND: Our aim was to evaluate the effect of FTY720 in discordant islet xenotransplantation.
METHODS: Fetal porcine islet-like cell clusters (ICCs) were transplanted into normoglycemic rats that were either left untreated or treated with FTY720 only, with FTY720 plus cyclosporine A (CsA) or with CsA only. Twelve or 24 days after transplantation, graft morphology was evaluated immunohistochemically. Furthermore, adult porcine islets (APIs) were transplanted into diabetic rats immunosuppressed with FTY720 plus CsA. Blood glucose and porcine C-peptide levels were monitored.
RESULTS: In untreated rats, the ICC xenografts were completely rejected after 12 days. Treatment with CsA had only a marginal effect on the rejection. In animals given FTY720, only the number of infiltrating cells was somewhat reduced. However, at 12 days, no intact ICCs remained. Immunosuppression with FTY720 plus CsA had a marked inhibitory effect on islet xenograft rejection and plentiful morphologically intact ICCs remained. Twelve days after transplantation, only occasional macrophages and T cells could be detected. At 24 days after transplantation, the findings were similar. Furthermore, diabetic rats transplanted with APIs and immunosuppressed with FTY720 plus CsA remained normoglycemic for 53.0+/-15.8 days. In fact, one animal remained normoglycemic for more than 100 days. Serum levels of porcine C-peptide remained at levels similar to those for human C-peptide in healthy individuals.
CONCLUSIONS: Immunosuppression with FTY720 plus CsA inhibited almost all morphological signs of pig-to-rat islet xenograft rejection for up to 24 days after transplantation. Diabetic rats transplanted with APIs and immunosuppressed with FTY720 plus CsA remained normoglycemic for 53.0+/-15.8 days.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12717240     DOI: 10.1097/01.TP.0000061770.39569.7F

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  6 in total

1.  Activation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemia-reperfusion injury.

Authors:  Amandeep Bajwa; Sang-Kyung Jo; Hong Ye; Liping Huang; Krishna R Dondeti; Diane L Rosin; Volker H Haase; Timothy L Macdonald; Kevin R Lynch; Mark D Okusa
Journal:  J Am Soc Nephrol       Date:  2010-03-25       Impact factor: 10.121

Review 2.  Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.

Authors:  William L Holland; Scott A Summers
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

3.  KRP-203 Is a Desirable Immunomodulator for Islet Allotransplantation.

Authors:  Ibrahim Fathi; Ryuichi Nishimura; Takehiro Imura; Akiko Inagaki; Norifumi Kanai; Akira Ushiyama; Masafumi Kikuchi; Masamitsu Maekawa; Hiroaki Yamaguchi; Masafumi Goto
Journal:  Transplantation       Date:  2021-07-01       Impact factor: 5.385

4.  Development of a novel method for measuring tissue oxygen pressure to improve the hypoxic condition in subcutaneous islet transplantation.

Authors:  Hiroaki Mitsugashira; Takehiro Imura; Akiko Inagaki; Yukiko Endo; Takumi Katano; Ryusuke Saito; Shigehito Miyagi; Kimiko Watanabe; Takashi Kamei; Michiaki Unno; Masafumi Goto
Journal:  Sci Rep       Date:  2022-08-30       Impact factor: 4.996

5.  Tacrolimus inhibits the revascularization of isolated pancreatic islets.

Authors:  Ryuichi Nishimura; Sho Nishioka; Ikuma Fujisawa; Hitoshi Shiku; Miki Shimada; Satoshi Sekiguchi; Keisei Fujimori; Akira Ushiyama; Tomokazu Matsue; Noriaki Ohuchi; Susumu Satomi; Masafumi Goto
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

6.  FTY720 Regulates Mitochondria Biogenesis in Dendritic Cells to Prevent Kidney Ischemic Reperfusion Injury.

Authors:  Thomas V Rousselle; Canan Kuscu; Cem Kuscu; Kailo Schlegel; LiPing Huang; Maria Namwanje; James D Eason; Liza Makowski; Daniel Maluf; Valeria Mas; Amandeep Bajwa
Journal:  Front Immunol       Date:  2020-06-23       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.